The Million Women Study

Results: 82



#Item
31NHS Breast Screening Programme Annual Review 2012 Contents 1

NHS Breast Screening Programme Annual Review 2012 Contents 1

Add to Reading List

Source URL: www.cancerscreening.nhs.uk

Language: English - Date: 2013-01-31 10:54:23
32CMDh_240_2011_Rev01_2012 06_clean

CMDh_240_2011_Rev01_2012 06_clean

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2014-12-08 04:57:15
33CMDh_240_2011_Rev01_2012 06_clean

CMDh_240_2011_Rev01_2012 06_clean

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2014-12-08 04:57:16
34The European Agency for the Evaluation of Medicinal Products Post-authorisation evaluation of medicines for human use London, 11 July 2001 Doc. Ref: EMEA/CPMP/PhVWP[removed]SPC Wording for

The European Agency for the Evaluation of Medicinal Products Post-authorisation evaluation of medicines for human use London, 11 July 2001 Doc. Ref: EMEA/CPMP/PhVWP[removed]SPC Wording for

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2006-12-28 07:32:01
35Breast Cancer CORE SPC TEXT 4.4 Special warnings and precautions for use Epidemiological studies have reported an increased risk of having breast cancer diagnosed in women taking oestrogens or oestrogenprogestagen combin

Breast Cancer CORE SPC TEXT 4.4 Special warnings and precautions for use Epidemiological studies have reported an increased risk of having breast cancer diagnosed in women taking oestrogens or oestrogenprogestagen combin

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2006-12-28 07:32:01
36Making decisions: Should I use hormone replacement therapy? (HRT) I N V E S T I N G I N AU S T R A L I A’ S H E A LT H  Acknowledgement

Making decisions: Should I use hormone replacement therapy? (HRT) I N V E S T I N G I N AU S T R A L I A’ S H E A LT H Acknowledgement

Add to Reading List

Source URL: www.nhmrc.gov.au

Language: English - Date: 2011-04-27 20:38:52
37CORE SPC FOR HORMONE REPLACEMENT THERAPY PRODUCTS  Doc. Ref.: CMDh[removed]Rev 4 June[removed]Therapeutic Indications 

CORE SPC FOR HORMONE REPLACEMENT THERAPY PRODUCTS Doc. Ref.: CMDh[removed]Rev 4 June[removed]Therapeutic Indications 

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2012-07-11 10:57:55
38Tibolone (Livial) and risk of VTE and other risks

Tibolone (Livial) and risk of VTE and other risks

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2012-01-05 11:33:35
39CORE SPC FOR HORMONE REPLACEMENT THERAPY PRODUCTS  Doc. Ref.: CMDh[removed]Rev 34 December 2009June[removed]Therapeutic Indications 

CORE SPC FOR HORMONE REPLACEMENT THERAPY PRODUCTS Doc. Ref.: CMDh[removed]Rev 34 December 2009June[removed]Therapeutic Indications 

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2012-07-11 10:57:56
40breast cancer  Breast cancer and exposure to hormonally active chemicals: An appraisal of the scientific evidence

breast cancer Breast cancer and exposure to hormonally active chemicals: An appraisal of the scientific evidence

Add to Reading List

Source URL: www.chemicalshealthmonitor.org

Language: English - Date: 2014-03-18 06:55:18